May 9, 2007
Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmaceuticals

April 26, 2007
Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds

February 26, 2007
Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds

January 11, 2007
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds

January 10, 2007
ERBITUX® Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer

December 28, 2006
Canadian Federal Court of Appeals Rules in sanofi-aventis' Favor in the Canadian Plavix Notice of Compliance Proceedings

December 27, 2006
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Announce Exclusive Licensing Agreement for Diabetes Compound Saxagliptin in Japan

December 18, 2006
Exelixis and Bristol-Myers Squibb Sign New Collaboration Agreement to Discover and Develop Novel Oncology Compounds

December 12, 2006
ABILIFY® (Aripiprazole) Injection for Intramuscular Use for Adults With Agitation Associated With Schizophrenia or Bipolar Mania Now Available

December 8, 2006
Preliminary Injunction Against Apotex Upheld on Appeal

December 7, 2006
ABILIFY® (aripiprazole) Demonstrated Efficacy as Long-Term Maintenance Therapy in Adults With Bipolar I Disorder Following Treatment for a Recent Manic Or Mixed Episode

November 6, 2006
Survival Data Available from Two Randomized ERBITUX® Studies in Metastatic Colorectal Cancer

October 9, 2006
Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit Marketing Authorisation Application for ATRIPLA™ (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) to European Medicines Agency

September 28, 2006
Bristol-Myers Squibb and Gilead Sciences Establish Agreement to Commercialize ATRIPLA™ (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) in Canada

September 21, 2006
Plavix® Preliminary Injunction Appeal

September 13, 2006
Bristol-Myers Squibb Company And Medivir AB Announce Worldwide Collaboration To Develop And Commercialize MIV-170 For The Treatment Of HIV-1 Infection In Adults

August 31, 2006
Preliminary Injunction Ordered in Plavix® Patent Infringement Case Apotex to Halt Sales of Unauthorized Generic

August 17, 2006
Bristol-Myers Squibb and Otsuka Pharmaceutical Company Launch New Rapidly Disintegrating Oral Antipsychotic Medication ABILIFY® DISCMELT™ (aripiprazole)

August 14, 2006
Motion Filed for Preliminary Injunction in PLAVIX® Patent Infringement Case

July 28, 2006
PLAVIX® Litigation Settlement Fails to Receive Antitrust Clearance From States Attorneys General